QUADRANT CAPITAL GROUP LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 191 filers reported holding MYRIAD GENETICS INC in Q1 2020. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$2,374
-65.0%
148
-49.5%
0.00%
-100.0%
Q2 2023$6,792
+28.2%
293
+28.5%
0.00%0.0%
Q1 2023$5,297
-36.1%
228
-60.1%
0.00%0.0%
Q4 2022$8,285
+107.1%
571
+205.3%
0.00%0.0%
Q3 2022$4,000
+33.3%
1870.0%0.00%
Q2 2022$3,000
+50.0%
187
+101.1%
0.00%
Q1 2022$2,000
-33.3%
930.0%0.00%
Q4 2021$3,0000.0%930.0%0.00%
Q3 2021$3,000
-90.6%
93
-96.7%
0.00%
-100.0%
Q2 2020$32,000
+14.3%
2,824
+168.4%
0.01%
+133.3%
Q4 2019$28,000
-3.4%
1,0520.0%0.00%
-25.0%
Q3 2019$29,000
+3.6%
1,0520.0%0.00%0.0%
Q2 2019$28,000
+1300.0%
1,052
+995.8%
0.00%
Q1 2019$2,000
+100.0%
96
+74.5%
0.00%
Q4 2018$1,000
-50.0%
550.0%0.00%
-100.0%
Q3 2018$2,0000.0%550.0%0.00%0.0%
Q2 2018$2,000
+100.0%
550.0%0.00%
Q1 2018$1,0000.0%550.0%0.00%
Q4 2017$1,0000.0%550.0%0.00%
Q3 2017$1,000550.0%0.00%
Q2 2017$0
-100.0%
550.0%0.00%
Q1 2017$1,000
-80.0%
55
-63.6%
0.00%
-100.0%
Q1 2016$5,0001510.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders